https://www.zonebourse.com/cours/action/ARIDIS-PHARMACEUTICALS-IN-45272048/actualite/L-anticorps-monoclonal-AR-301-d-Aridis-est-l-un-des-premiers-produits-biologiques-a-recevoir-la-de-44322960/?utm_source=telegram&utm_medium=social&utm_campaign=share